(Q38514724)

3 September 2017

Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro (English)

1 reference

3 September 2017

1 reference

1 reference

Liu KH

1

1 reference

3 September 2017

Kim MJ

2

1 reference

3 September 2017

Shon JH

3

1 reference

3 September 2017

Moon YS

4

1 reference

3 September 2017

Seol SY

5

1 reference

3 September 2017

Kang W

6

1 reference

3 September 2017

Cha IJ

7

1 reference

3 September 2017

Shin JG

8

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

3 September 2017

1 reference

3 September 2017

35

1 reference

3 September 2017

1

1 reference

3 September 2017

27-38

1 reference

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

3 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Activation of CYP2C9-mediated metabolism by a series of dapsone analogs: kinetics and structural requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Influence of lansoprazole treatment on diazepam plasma concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

(+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

A study of the interaction of omeprazole and warfarin in anticoagulated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

Propranolol steady-state pharmacokinetics are unaltered by omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250400026472

10.1080/00498250400026472

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference